PDA responds to the PSA’s proposed changes to regulator performance reviews

The Professional Standard Authority (PSA) oversees 10 healthcare regulators (including the GPhC and PSNI) across the UK and must submit an annual report to Parliament on how well these 10 regulators have discharged their duties. The PSA recently consulted on proposals to change how it reviews the performance of regulators.

Mon 12th April 2021 The PDA

The PDA has responded to this consultation titled “Consultation on our approach to Performance Review.”

The consultation sought views on the scope of the review process:

  • Should all of the Standards of Good Regulation be assessed annually for all the regulators?
  • Assessing risk: how can we best identify risks to public protection and public confidence through the performance review process?
  • Decision-making: should we retain the current binary system – where regulators meet or do not meet a Standard – or adopt a different approach?
  • Supporting improvement: how can we ensure that our performance reviews add the greatest value and enhance the work of the regulators in protecting the public?
  • Thematic reviews: do you think thematic reviews would assist us in our scrutiny of the regulators and enhance our public protection role?

The PSA currently publishes a comprehensive annual performance review for each of the 10 regulators. The process is detailed even though some regulators find it inefficient. The reviews and narrative contain details that would otherwise not be available to the public or registrants.

The narrative is especially relevant and gives context to the review and how the PSA has measured the performance of each regulator against 18 standards. These 18 standards, which the PSA assesses as being met or not met, are informed by the authority’s principles of good regulation which states that regulators should act in a way which is:

  • Proportionate
  • Consistent
  • Targeted
  • Transparent
  • Accountable
  • Agile.

The PSA proposed that instead of an annual performance review each regulator would still have a comprehensive performance review but only twice in each decade. The PSA proposed receiving enhanced datasets from the regulators and when needed it would perform a targeted review.

The PDA has found the comprehensive PSA annual performance reviews useful. The last 2 performance reviews of the GPhC found that there were significant concerns about how the GPhC manages fitness to practice concerns. It was only through these published performance reviews that these problems were identified.

Download the PDA’s full response here

thumbnail of 02 PSA Perf Rev consult FINAL

Download the consultation document here

 

thumbnail of 01 Performance Review consultation

The consultation closed on 04/03/2021.

 

 

 

The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)